Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3397466 | Clinical Microbiology and Infection | 2010 | 5 Pages |
Abstract
In 2007, a significant increase in acquired ampC genes in Enterobacteriaceae from 0.06% in 1999 to 1.3% was observed. Proteus mirabilis showed the highest prevalence (0.95%) and CMY-2 was the most prevalent AmpC enzyme (66.7%). Other enzymes such as CMY-4, DHA-1, ACC-1, and three new enzymes called CMY-25, CMY-27 and CMY-40 were detected. Seven out of the 117 isolates (6%) also produced an extended-spectrum β-lactamase. As acquired AmpC enzymes are likely to become a serious public health issue worldwide, close surveillance is necessary to curb their spread.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
C. Mata, E. Miró, A. Rivera, B. Mirelis, P. Coll, F. Navarro,